Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $2.0 million.

  • Biofrontera's Cost of Revenue fell 5806.85% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 1040.99%. This contributed to the annual value of $18.6 million for FY2024, which is 666.7% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Cost of Revenue is $2.0 million, which was down 5806.85% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Cost of Revenue ranged from a high of $17.5 million in Q4 2022 and a low of -$1.4 million during Q4 2023
  • Moreover, its 5-year median value for Cost of Revenue was $2.6 million (2025), whereas its average is $3.4 million.
  • In the last 5 years, Biofrontera's Cost of Revenue skyrocketed by 955469.61% in 2022 and then plummeted by 10775.97% in 2023.
  • Biofrontera's Cost of Revenue (Quarter) stood at $181000.0 in 2021, then skyrocketed by 9554.7% to $17.5 million in 2022, then crashed by 107.76% to -$1.4 million in 2023, then surged by 488.72% to $5.3 million in 2024, then tumbled by 61.2% to $2.0 million in 2025.
  • Its Cost of Revenue stands at $2.0 million for Q3 2025, versus $2.6 million for Q2 2025 and $3.3 million for Q1 2025.